Non-invasive technologies represent an exciting frontier in diabetes research, holding the potential to improve the lives of over four hundred million people worldwide. Glucose monitoring devices are aimed to further advance this scope by providing means to monitor glucose levels without pricking the skin barrier. These devices can enable continuous readings such as Continuous Glucose Monitoring (CGM) or intermittent readings where users actively perform measurements. Despite these attractive prospects, a large shadow looms over the sector in the form of relentless downward pressure on pricing. Meanwhile, the government is desperately trying to reduce the cost of healthcare, especially in the most expensive part of the system – the hospitals.
As a result, industry executives need to challenge conventional thinking and re-imagine the roles their companies will play in 2021. Accordingly, they will need to reconfigure today’s organization to shift from being a participant to being a solution provider for sustainable healthcare costs. To help companies navigate through the best-of-breed non-invasive device companies, our editorial board has compiled a list of “Top 5 Non Invasive Device Consulting/Service Companies in Europe – 2020.” The enlisted organizations are transforming business processes at the intersection of various disruptive technologies. We hope this edition of MedTech Outlook helps you build a partnership to boost productivity and efficiency.
